Common Contracts
2 similar Securities Purchase Agreement contracts by Cardiff Oncology, Inc., Cyclacel Pharmaceuticals, Inc.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 22nd, 2020 • Cyclacel Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of December 18, 2020, is by and among Cyclacel Pharmaceuticals, Inc., a Delaware corporation with headquarters located at 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922 (the “Company”), and Acorn Bioventures, L.P., a Delaware limited partnership (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 27th, 2020 • Cardiff Oncology, Inc. • Biological products, (no disgnostic substances) • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of May 26, 2020, is by and among Cardiff Oncology, Inc., a Delaware corporation with headquarters located at 11055 Flintkote Avenue, San Diego, CA 92121 (the ”Company”), and Acorn Bioventures, L.P., a Delaware limited partnership (the “Buyer”).
